The past decade has been a game-changing one for Vertex Pharmaceuticals (NASDAQ: VRTX). The biotech won approval for its ...

There are hundreds of publicly traded companies on various equity markets worldwide. Investors choose to put their ...

Vertex Pharmaceuticals operates in a profitable subsector and is poised for further success, says Dr Michael Tubbs ...

Vertex Pharmaceuticals Inc. (NASDAQ:VRTX) has recently achieved a significant milestone with the FDA's approval of JOURNAVX(suzetrigine), a novel non-opioid pain medication. This approval marks ...

Vertex Pharmaceuticals and AstraZeneca faced ... However, AstraZeneca's legal problems stem from its operations in China, which strongly suggests wrongdoing by specific people affiliated with ...

Now the tricky thing about CF is different gene mutations cause different problems with the protein, but Vertex has managed to develop medicines that are able to treat about 90% of CF patients.